Therapy News and Research

RSS

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital

7 Jul 2004

Research to unravel exactly what is going on chemically, when Alzheimer's sets in

Science understands Alzheimer's disease as the progressive decline of a particular region of the brain. But the underlying mechanisms leading to this decline are still very much a mystery.

7 Jul 2004

Anticoagulant therapy with enoxaparin is an effective alternative to heparin therapy for patients with acute coronary syndromes

Two new major studies suggest that anticoagulant therapy with enoxaparin is an effective alternative to heparin therapy for patients with acute coronary syndromes (ACS)

7 Jul 2004

Soy protein not effective in improving memory in post menopausal women

No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year

7 Jul 2004

Convincing evidence that at dietary levels, the estrogens found in soy do not stimulate cell growth and other markers for cancer risk

New research in monkeys suggests that a diet high in the natural plant estrogens found in soy does not increase the risk of breast or uterine cancer in postmenopausal women.

7 Jul 2004

New Zealand research to help reduce depression amongst stroke victims

Every year thousands of New Zealanders have a stroke and about a third of them experience “post-stroke depression”, something a researcher at The University of Auckland is hoping she can change.

6 Jul 2004

NovoSeven may prove to be the first effective treatment for brain hemorrhage caused by stroke

Scientists from the UC Medical Center played a key role in developing what may prove to be the first effective treatment for brain hemorrhage caused by stroke.

5 Jul 2004

Gene therapy may provide a treatment for a group of incurable, progressive neurological diseases called polyglutamine-repeat diseases

Researchers from the University of Iowa have have shown for the first time that gene therapy delivered to the brains of living mice can prevent the physical symptoms and neurological damage caused by an inherited neurodegenerative disease that is similar to Huntington's disease (HD).

5 Jul 2004

Fear of flying and gender differences, women are afraid to crash - men fear lack of control

2.5 million Dutch suffer from fear of flying. Psychologist and pilot Lucas van Gerwen took his doctoral degree at the University of Leiden in June.

5 Jul 2004

A new protocol for bone marrow transplants

A new protocol for bone marrow transplants, which does not require the destruction of the recipient’s immune system before transfer of the new bone marrow, is described by a group of Oxford scientists

5 Jul 2004

Nanotechnology-based applications are accelerating the development of nanomedicine

With the potential for targeted therapy, and therefore reduced side effects, nanomedicine holds the promise of significantly improving quality of life parameters.

5 Jul 2004

Treatment of chronic hepatitis C with interferon can be ineffective due to relapse

Treatment of chronic hepatitis C with interferon can be ineffective due to relapse. We aimed to reduce the 40% relapse rate of 6 months interferon–ribavirin combination therapy by prolonging treatment to 18 months.

4 Jul 2004

Questions about this once widely-accepted treatment for postmenopausal ills

In the past two years, the Women’s Health Initiative (WHI) trials of Premarin-based hormone therapy came to early ends because the risks outweighed the benefits.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Omega-3's - fatty acids, can be produced in bioengineered plants

Long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs) have benefits regarding cardiovascular and inflammatory function, certain types of cancer, and maternal and infant health, according to recent peer-reviewed studies.

2 Jul 2004

Computer learning better than traditional counseling when educating injection drug users about HIV/AIDS

Injection drug users who studied HIV/AIDS causes and prevention via computer learned more about the disease than users who attended traditional counseling sessions, according to new research.

1 Jul 2004

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.

1 Jul 2004

Mucus may be the key to new treatments for cystic fibrosis

The surprising finding that people with cystic fibrosis (CF) produce too little airway mucus – rather than too much, as it commonly believed

1 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for regulatory approval of exenatide.

1 Jul 2004

Therapy News and Research

Combining targeted immunotherapy with chemotherapy and radiation therapy to successfully kill metastatic tumour cells

Research to unravel exactly what is going on chemically, when Alzheimer's sets in

Anticoagulant therapy with enoxaparin is an effective alternative to heparin therapy for patients with acute coronary syndromes

Soy protein not effective in improving memory in post menopausal women

Convincing evidence that at dietary levels, the estrogens found in soy do not stimulate cell growth and other markers for cancer risk

New Zealand research to help reduce depression amongst stroke victims

NovoSeven may prove to be the first effective treatment for brain hemorrhage caused by stroke

Gene therapy may provide a treatment for a group of incurable, progressive neurological diseases called polyglutamine-repeat diseases

Fear of flying and gender differences, women are afraid to crash - men fear lack of control

A new protocol for bone marrow transplants

Nanotechnology-based applications are accelerating the development of nanomedicine

Treatment of chronic hepatitis C with interferon can be ineffective due to relapse

Questions about this once widely-accepted treatment for postmenopausal ills

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Omega-3's - fatty acids, can be produced in bioengineered plants

Computer learning better than traditional counseling when educating injection drug users about HIV/AIDS

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Mucus may be the key to new treatments for cystic fibrosis

TUNA therapy results in significantly reduced erectile dysfunction

New drug application for regulatory approval of exenatide for the treatment of type 2 diabetes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News